Acquired Immunodeficiency Syndrome and the Eye—1996

Archives of Ophthalmology

Volumn 114, Issue 7, 1996, Pages 863-866

  Jabs, Douglas A ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADULT; AIDS RELATED COMPLEX; EDITORIAL; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; RETINITIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS RETINITIS; FEMALE; HUMANS; MALE;

EID: 0030192080     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100140077013     Document Type: Article

References (61)

1. Centers for Disease Control and Prevention. US HIV and AIDS cases reported through December 1994. HIV/AIDS Surveill Rep. 1995;6:1-39.
2. Centers for Disease Control and Prevention. Cases of selected notifiable diseases in United States, weeks ending December 30, 1995 and December 31, 1994 (52nd week). MMWR Morb Mortal Wkly Rep. 1996;45:23-26.
3. Centers for Disease Control and Prevention. HIV prevalence case projections for the estimates and AIDS, United States: report based upon a workshop. MMWR Morb Mortal Wkly Rep. 1990;39[RR-16]:1-31.
4. Centers for Disease Control and Prevention. Update: mortality attribute to HIV infection among persons aged 25-44 years—United States, 1994. MMWR Morb Mortal Wkly Rep. 1996;45:121-124.
5. Jabs DA. Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc. 1995;93:623-683.
6. Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY. Acquired immune deficiency syndrome: pathogenic mechanisms of ocular disease. Ophthalmology. 1985;92:472-484.
7. Newsome DA, Green WR, Miller ED, et al. Microvascular aspects of acquired immune deficiency syndrome retinopathy. Am J Ophthalmol. 1984;98:590-601.
8. Pomerantz RJ, Kuritzkes DR, De La Monte SM, et al. Infection of the retina by human immunodefiency virus type 1. N Engl J Med. 1987;317:1643-1647.
9. Engstrom RE, Holland GN, Hardy WD, Meiselman HJ. Hemorheologic abnormalities in patients with human immunodeficiency virus infection and ophthalmic microvasculopathy. Am J Ophthalmol. 1990;109:153-161.
10. Thierfelder S, Linnert D, Grehn F. Increased prevalence of HIV-related retinal microangiopathy syndrome in patients with hepatitis C. Arch Ophthalmol. 1996;114:894.
11. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis. 1992;166:1223-1227.
12. Pertel P, Hirschtick R, Phair J, Chmiel J, Poggensee L, Murphy R. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol. 1992;5:1069-1074.
13. Kupperman BD, Petty JG, Richman DD, et al. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virusrelated noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993;115:575-582.
14. Hoover DR, Peng Y, Saah A, et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression.Arch Ophthalmol. 1996;114:821-827.
15. Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Engl J Med. 1993;329:1922-1926.
16. Wilhelmus KR, Font RL, Lehmann RP, Cernoch PL. Cytomegalovirus keratitis in acquired immunodeficiency syndrome. Arch Ophthalmol. 1996;114:869-872.
17. Baldassano V, Dunn JP, Feinberg J, Jabs DA. Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts. N Engl J Med. 1995;333:670.
18. Plummer DJ, Arevalo JF, Fram N, Quiceno JI, Sample PA, Freeman WR. Effectiveness of entoptic perimetry for locating peripheral scotomas caused by cytomegalovirus retinitis. Arch Ophthalmol. 1996;114:828-831.
19. Spector SA, Weingeist T, Pollard RB, et al. A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. J Infect Dis. 1993;168:557-563.
20. Palestine AG, Polis MA, De Smet MD, et al. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med. 1991;115:665-673.
21. Martin DF, Parks DJ, Mellow SD, et al. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant: a randomized controlled clinical trial. Arch Ophthalmol. 1994;112:1531-1539.
22. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med. 1992;326:213-220.
23. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Foscarnet-ganciclovir cytomegalovirus retinitis trial, 4: visual outcomes. Ophthalmology. 1994;101:1250-1261.
24. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trial Group. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Arch Intern Med. 1995;155:65-74.
25. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. Arch Ophthalmol. 1996;114:23-33.
26. The Oral Ganciclovir European and Australian Cooperative Study Group. Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. AIDS. 1995;9:471-477.
27. Drew WL, Ives D, Lalexari JP, et al. Oral ganciclvir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N Engl J Med. 1995;333:615-620.
28. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Clinical vs photographic assessment of treatment of cytomegalovirus retinitis: foscarnet-ganciclovir cytomegalovirus retinitis trial report 8. Arch Ophthalmol. 1996;114:848-855.
29. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Assessment of cytomegalovirus retinitis: clinical evaluation vs centralized grading of fundus photographs. Arch Ophthalmol. 1996;114:791-805.
30. Holland GN, Buhles WC Jr, Mastre B, Kaplan HJ. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy: use of a standardized system for the assessment of disease outcome. Arch Ophthalmol. 1989;107:1759-1766.
31. Wu AW, Coleson LC, Holbrook J, Jabs DA. Measuring visual function and quality of life in patients with cytomegalovirus retinitis. Arch Ophthalmol. 1996;114:841-847.
32. Glasgow BJ, Engstrom RE, Holland GN, Kreiger AE, Wool MG. Bilateral endogenous Fusarium endophthalmitis associated with acquired immunodeficiency syndrome. Arch Ophthalmol. 1996;114:873-877.
33. Walton RC, Wilson J, Chan C-C. Metastatic choroidal abscess in the acquired immunodeficiency syndrome. Arch Ophthalmol. 1996;114:880-881.
34. Tufail A, Weisz JM, Holland GN. Endogenous bacterial endophthalmitis as a complication of intravenous therapy for cytomegalovirus retinopathy. Arch Ophthalmol. 1996;114:879-880.
35. Pepose JS, Newman C, Bach MC, et al. Pathologic features of cytomegalovirus retinopathy after treatment with the antiviral agent ganciclovir. Ophthalmology. 1987;94:414-424.
36. Burd EM, Pulido JS, Puro DG, O'Brien WJ. Maintenance of replicative intermediates in ganciclovir-treated human cytomegalovirus-infected retinal glia. Arch Ophthalmol. 1996;114:856-861.
37. Duker JS, Davis JL, Chuang E, Keller R, Ashton P. Long-term, successful maintenance of bilateral cytomegalovirus retinitis using exclusively local therapy. Arch Ophthalmol. 1996;114:881-882.
38. Marx JL, Kapusta MA, Patel SS, et al. Use of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitis. Arch Ophthalmol. 1996;114:815.
39. Jabs DA, Enger C, Haller J, de Bustros S. Retinal detachments in patients with cytomegalovirus retinitis. Arch Ophthalmol. 1991;109:794-799.
40. Freeman WR, Henderly DE, Wan WL, et al. Prevalence, pathophysiology, and treatment of rhegmatogenous retinal detachment in treated cytomegalovirus retinitis. Am J Ophthalmol. 1987;103:527-536.
41. Freeman WR, Friedberg DN, Berry C, et al. Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol. 1993;116:713-720.
42. Gangan PA, Besen G, Munguia D, Freeman WR. Macular serous exudation in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. Am J Ophthalmol. 1994;118:212-219.
43. Dodds EM, Lowder CY, Foster RE, Avery RK, Prayson RA. Serous retinal detachments in a patient with clinically resistant cytomegalovirus retinitis. Arch Ophthalmol. 1996;114:896-897.
44. Lim JI, Enger C, Haller JA, et al. Improved visual results after surgical repair of cytomegalovirus-related retinal detachments. Ophthalmology. 1994;101:264-269.
45. Kuppermann BD, Flores-Aguilar M, Quiceno JI, et al. A masked prospective evaluation of outcome parameters for cytomegalovirus-related retinal detachment surgery in patients with acquired immune deficiency syndrome. Ophthalmology. 1994;101:46-55.
46. Davis JL, Serfass MS, Lai MY, Trask DK, Azen SP. Silicone oil in repair of retinal detachments caused by necrotizing retinitis in HIV infection. Arch Ophthalmol. 1995;113:1401-1409.
47. Meldrum ML, Aaberg TM, Patel A, Davis J. Cataract extraction after silicone oil repair of retinal detachments due to necrotizing retinitis. Arch Ophthalmol. 1996;114:885-892.
48. Drew WL, Miner RC, Busch DF, et al. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis. 1991;163:716-719.
49. Erice A, Chou S, Biron KK, Stanat SC, Balfour HH, Jordan MC. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med. 1989;320:289-293.
50. Leport C, Puget S, Pepin JM, et al. Cytomegalovirus resistant to foscarnet: clinicovirologic correlation in a patient with human immunodeficiency virus. J Infect Dis. 1991;168:1329-1330.
51. Flores-Aguilar M, Kupperman BD, Quiceno JI, et al. Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis. Ophthalmology. 1993;100:1022-1031.
52. Dunn JP, MacCumber MW, Forman MS, Charache P, Apuzzo L, Jabs DA. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir. Am J Ophthalmol. 1995;119:587-596.
53. Jabs DA, Dunn JP, Enger C, et al. Cytomegalovirus retinitis and viral resistance: prevalence of resistance at diagnosis, 1994. Arch Ophthalmol. 1996;114:809-814.
54. Rao NA, Zimmerman PL, Boyer D, et al. A clinical, histologic, and electron microscopic study of Pneumocystis carinii choroiditis. Am J Ophthalmol. 1989;107:218-228.
55. Shami MJ, Freeman WR, Friedberg D, Siderides E, Listhaus A, Ai E.A multicenter study of Pneumocystis choroidopathy. Am J Ophthalmol. 1991;112:15-22.
56. Friedberg DN, Stenson SM, Orenstein JM, Tierno PM, Charles NC. Microsporidial keratoconjunctivitis in acquired immunodefiency syndrome. Arch Ophthalmol. 1990;108:504-508.
57. Forster DJ, Dugel PU, Frangieh GT, Liggett PE, Rao NA. Rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome. Am J Ophthalmol. 1990;110:341-348.
58. Margolis TP, Lowder CY, Holland GN, et al. Varicella-zoster virus retinitis in patients with the acquired immunodefiency syndrome. Am J Ophthalmol. 1991;112:119-131.
59. Engstrom RE, Holland GN, Margolis TP, et al. The progressive outer retinal necrosis syndrome. Ophthalmology. 1994;101:1488-1502.
60. Cunningham ET, Short GA, Irvine AR, Duker JS, Margolis TP. Acquired immunodeficiency syndrome—associated herpes simplex virus retinitis: clinical description and use of a polymerase chain reaction—based assay as a diagnostic tool. Arch Ophthalmol. 1996;114:834-840.
61. Elkins BS, Holland GN, Opremcak EM, et al. Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients. Ophthalmology. 1994;101:499-507.